Mild Neurological Phenotype Associated with Hypomorphic Variants in the Ataxia-Telangiectasia Mutated Gene.

functional studies kinase activity mild phenotype p53‐MCL variant ataxia‐telangiectasia

Journal

Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 27 07 2022
revised: 02 10 2022
accepted: 29 10 2022
entrez: 27 1 2023
pubmed: 28 1 2023
medline: 28 1 2023
Statut: epublish

Résumé

Ataxia-telangiectasia (A-T) is a progressive multisystemic neurodegenerative disease. The phenotypic spectrum includes conditions (variant A-T) with mild, late-onset, and atypical clinical presentations characterized by the prevalence of dyskinetic rather than ataxic features. We describe the clinical presentations of 3 siblings with early-onset truncal ataxia without obvious neurological deterioration or biological markers of classic A-T phenotype. We performed functional and genetic evaluation of 3 siblings with very mild neurological phenotype. Genetic evaluation with a next-generation sequencing panel for genes causative of cerebellar ataxia detected 2 known ATM gene variants, missense c.9023G>A p.(Arg3008His), and leaky splicing c.1066-6T>G variants. Functional studies showed mildly reduced ATM expression and residual kinase activity in the probands compared with healthy controls. These results suggest the importance of investigating ATM variants even in the presence of clinical and biological atypical cases to ensure specific therapeutic regimens and oncological surveillance in these patients.

Sections du résumé

Background UNASSIGNED
Ataxia-telangiectasia (A-T) is a progressive multisystemic neurodegenerative disease. The phenotypic spectrum includes conditions (variant A-T) with mild, late-onset, and atypical clinical presentations characterized by the prevalence of dyskinetic rather than ataxic features.
Cases UNASSIGNED
We describe the clinical presentations of 3 siblings with early-onset truncal ataxia without obvious neurological deterioration or biological markers of classic A-T phenotype. We performed functional and genetic evaluation of 3 siblings with very mild neurological phenotype. Genetic evaluation with a next-generation sequencing panel for genes causative of cerebellar ataxia detected 2 known ATM gene variants, missense c.9023G>A p.(Arg3008His), and leaky splicing c.1066-6T>G variants. Functional studies showed mildly reduced ATM expression and residual kinase activity in the probands compared with healthy controls.
Conclusions UNASSIGNED
These results suggest the importance of investigating ATM variants even in the presence of clinical and biological atypical cases to ensure specific therapeutic regimens and oncological surveillance in these patients.

Identifiants

pubmed: 36704080
doi: 10.1002/mdc3.13618
pii: MDC313618
pmc: PMC9847291
doi:

Types de publication

Case Reports

Langues

eng

Pagination

124-129

Informations de copyright

© 2022 International Parkinson and Movement Disorder Society.

Références

Hum Mutat. 2003 May;21(5):521-8
pubmed: 12673794
J Clin Invest. 2013 Mar;123(3):1335-42
pubmed: 23454770
Orphanet J Rare Dis. 2016 Nov 25;11(1):159
pubmed: 27884168
Am J Hum Genet. 2009 Oct;85(4):427-46
pubmed: 19781682
Cancer Res. 2001 Oct 15;61(20):7608-15
pubmed: 11606401
Am J Med Genet A. 2020 Dec;182(12):2971-2975
pubmed: 32918381
Breast Cancer Res Treat. 2010 Jan;119(2):443-52
pubmed: 19404735
Ann Neurol. 2019 Feb;85(2):170-180
pubmed: 30549301
Cancer Res. 2021 Jan 15;81(2):426-437
pubmed: 33239428
Neurol Genet. 2018 Mar 27;4(2):e228
pubmed: 29600275
Clin Chem. 2021 Mar 1;67(3):518-533
pubmed: 33280026
Eur J Pediatr. 1993 Jul;152(7):609-12
pubmed: 7689057
Hum Mutat. 2019 Oct;40(10):1713-1730
pubmed: 31050087
Hum Mutat. 2005 Jun;25(6):594-5
pubmed: 15880680
Clin Case Rep. 2020 Dec 30;9(2):995-1009
pubmed: 33598286
Br J Haematol. 2008 Sep;142(6):925-33
pubmed: 18573109

Auteurs

Caterina Caputi (C)

Department of Human Neuroscience Sapienza University Rome Italy.

Giulia Federici (G)

Unit of Cellular Networks and Molecular Therapeutic Targets Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute Rome Italy.

Silvia Soddu (S)

Unit of Cellular Networks and Molecular Therapeutic Targets Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute Rome Italy.

Lorena Travaglini (L)

Unit of Neuromuscular and Neurodegenerative Diseases Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Bambino Gesù Children's Hospital Rome Italy.

Maria Piane (M)

Department of Clinical and Molecular Medicine Sapienza University Rome Italy.

Enrico Bertini (E)

Unit of Neuromuscular and Neurodegenerative Diseases Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Bambino Gesù Children's Hospital Rome Italy.

Ginevra Zanni (G)

Unit of Neuromuscular and Neurodegenerative Diseases Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Bambino Gesù Children's Hospital Rome Italy.

Vincenzo Leuzzi (V)

Department of Human Neuroscience Sapienza University Rome Italy.

Classifications MeSH